134 related articles for article (PubMed ID: 38061743)
1. Cutaneous Mixed Pseudolymphoma Induced by a Gold Needle Embedded in the Back.
Kim JK; Chun EJ; Yang SY; Kim SS; Kim CW
Ann Dermatol; 2023 Nov; 35(Suppl 2):S357-S358. PubMed ID: 38061743
[No Abstract] [Full Text] [Related]
2. Tattoo ink-related cutaneous pseudolymphoma: a rare but significant complication. Case report and review of the literature.
Marchesi A; Parodi PC; Brioschi M; Marchesi M; Bruni B; Cangi MG; Vaienti L
Aesthetic Plast Surg; 2014 Apr; 38(2):471-8. PubMed ID: 24570180
[TBL] [Abstract][Full Text] [Related]
3. Late cutaneous B-cell pseudolymphoma after an upper-eyelid gold weight implant.
Rodríguez-Villa Lario A; Medina-Montalvo S; Gómez-Zubiaur A; Montes-Mollón MÁ; Álvarez-Castro Y; Piteiro-Bermejo AB; Trasobares-Marugán L
Contact Dermatitis; 2019 Apr; 80(4):256-258. PubMed ID: 30520066
[No Abstract] [Full Text] [Related]
4. Cutaneous pseudolymphoma after patch test to gold sodium thiosulfate in two patients.
García-Arpa M; Gómez-Torrijos E; Relea-Calatayud F; Santiago-Sánchez Mateos JL; Galindo-Bonilla PA; Carmona-Rodríguez M
Contact Dermatitis; 2020 May; 82(5):322-324. PubMed ID: 31925792
[No Abstract] [Full Text] [Related]
5. Cutaneous pseudolymphoma: an unusual presentation of a scalp mass.
Nnebe NV; Woon C; Haines S; Dayton V; Weigel BJ
Pediatr Blood Cancer; 2009 Feb; 52(2):283-5. PubMed ID: 18839432
[TBL] [Abstract][Full Text] [Related]
6. CD30-positive T-cell-rich pseudolymphoma induced by gold acupuncture.
Kim KJ; Lee MW; Choi JH; Sung KJ; Moon KC; Koh JK
Br J Dermatol; 2002 May; 146(5):882-4. PubMed ID: 12000389
[TBL] [Abstract][Full Text] [Related]
7. Differential NFATc1 Expression in Primary Cutaneous CD4+ Small/Medium-Sized Pleomorphic T-Cell Lymphoma and Other Forms of Cutaneous T-Cell Lymphoma and Pseudolymphoma.
Magro CM; Momtahen S
Am J Dermatopathol; 2017 Feb; 39(2):95-103. PubMed ID: 27097342
[TBL] [Abstract][Full Text] [Related]
8. Pseudolymphoma and cutaneous lymphoma: facts and controversies.
Bergman R
Clin Dermatol; 2010; 28(5):568-74. PubMed ID: 20797521
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous pseudolymphoma: A clinicopathological study and immunohistochemical patterns.
Sari Aslani F; Sepaskhah M; Safaei A; Jashounia Hormozi S
Caspian J Intern Med; 2021 Apr; 12(3):283-289. PubMed ID: 34221277
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous pseudolymphoma due to topical application of 4% hydroquinone cream for melasma.
Dar NR; Shaheen ; Mustafvi SA; Raza N
J Coll Physicians Surg Pak; 2005 Aug; 15(8):496-7. PubMed ID: 16202363
[TBL] [Abstract][Full Text] [Related]
11. Persistent cutaneous pseudolymphoma after intradermal gold injection.
Kalimo K; Räsänen L; Aho H; Mäki J; Mustikkamki UP; Rantala I
J Cutan Pathol; 1996 Aug; 23(4):328-34. PubMed ID: 8864920
[TBL] [Abstract][Full Text] [Related]
12. Pseudolymphoma Due to Gold Sodium Thiosulfate.
Shpadaruk V; Maidment G; Burova E
Dermatitis; 2020; 31(1):e1-e2. PubMed ID: 31905183
[No Abstract] [Full Text] [Related]
13. Cutaneous pseudolymphoma: an unusual eyelid presentation.
Cloke A; Lim LT; Crofts KP
Semin Ophthalmol; 2012; 27(1-2):35-6. PubMed ID: 22352826
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous Pseudolymphoma.
Mitteldorf C; Kempf W
Surg Pathol Clin; 2017 Jun; 10(2):455-476. PubMed ID: 28477891
[TBL] [Abstract][Full Text] [Related]
15. Case of immunoglobulin G4-related skin disease: possible immunoglobulin G4-related skin disease cases in cutaneous pseudolymphoma only by immunohistochemical analysis.
Iwata Y; Mizoguchi Y; Takahashi M; Tanaka B; Kuroda M; Yagami A; Matsunaga K
J Dermatol; 2013 Dec; 40(12):998-1003. PubMed ID: 24303847
[TBL] [Abstract][Full Text] [Related]
16. Progression of cutaneous B-cell pseudolymphoma to cutaneous B-cell lymphoma.
Kulow BF; Cualing H; Steele P; VanHorn J; Breneman JC; Mutasim DF; Breneman DL
J Cutan Med Surg; 2002; 6(6):519-28. PubMed ID: 12404039
[TBL] [Abstract][Full Text] [Related]
17. [Cutaneous pseudolymphoma as an alternative presentation of IgG4 related disease].
Eddou H; Le Guyadec T; Cremades A; Saint Blancard P; Malfuson JV; Konopacki J; de Revel T
Ann Biol Clin (Paris); 2013; 71(3):333-7. PubMed ID: 23747671
[TBL] [Abstract][Full Text] [Related]
18. [Cutaneous pseudolymphoma caused by carbamazepine].
d'Incan M; Mouillet ML; Roger H; Ferrier MC; Buono JP; Déchelotte P; Bignon YJ; Souteyrand P
Ann Dermatol Venereol; 1998 Jan; 125(1):52-5. PubMed ID: 9747211
[TBL] [Abstract][Full Text] [Related]
19. Phenytoin Induced Cutaneous B Cell Pseudolymphoma.
Riyaz N; Sasidharanpillai S; Aravindan KP; Nobin BK; Raghavan NT; Nikhila PK
Indian J Dermatol; 2015; 60(5):522. PubMed ID: 26538730
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous MALT-lymphoma: from cutaneous immunocytoma and pseudolymphoma to the current (and future) conceptions.
Fernandez-Flores A
Rom J Morphol Embryol; 2013; 54(1):7-12. PubMed ID: 23529303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
